Bradley Hasson MilliporeSigma

Bradley Hasson is the Director of Lab Operations for Next Generation Sequencing Services at Merck KGaA. Brad leads a team of Scientists, laboratory technicians and bioinformaticians that perform NGS-based biosafety testing services in support of product characterization and release worldwide. He has 15 years of experience developing and implementing molecular-based methods for the purposes of Adventitious Agent Detection in a variety of biologically derived products.